Abbott Laboratories

ABT

NYSE

Last Updated: 12/1/2023 9:00:02 PM

Price

104.88

Changes

0.59

% Change

0.57

Volume

4649903

52 Week
High

115.83

52 Week
Low

89.67

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories Company Details

CEO: Mr. Robert B. Ford

Country: US

Industry: Medical Devices

Website: https://www.abbott.com

Exchange: New York Stock Exchange

IPO\Launch Date: 1980-03-17

Abbott Laboratories Company Executive Details

Mr. Robert E. Funck Jr.

Executive Vice President of Fin.

Mr. Robert E. Funck Jr.

Executive Vice President of Finance

Mr. Philip P. Boudreau

Chief Financial Officer & Senior Vice President of Fin.

Mr. Hubert L. Allen

Executive Vice President, General Counsel & Secretary

Mr. Daniel Gesua Sive Salvadori

Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products

Abbott Laboratories Latest News

Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio

In 2023, AI and the Magnificent 7 took the lead, leaving non-tech blue chip companies trailing behind in the rearview mirror. Abbott Laboratories had a difficult last three years, with its stock price trading sideways as sales driven by COVID-19 plummeted. Yet, Abbott operates a recession-proof business model with long-term tailwinds, its core business growing at double digits.

Published on: 2023-12-03 04:00:32